Evaluating the effect of immunisation with group B meningococcal vaccines on meningococcal carriage
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2019
Price : $35 *
At a glance
- Drugs Meningococcal vaccine group B (Primary)
- Indications Meningococcal group B infections
- Focus Therapeutic Use
- Acronyms Be on the TEAM; TEAM
- 19 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 19 Nov 2019 Status changed from active, no longer recruiting to recruiting.
- 19 Mar 2018 New trial record